Teva Pharmaceutical Industries
- Country
- 🇮🇱Israel
- Ownership
- -
- Employees
- 37.8K
- Market Cap
- $21.2B
- Introduction
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
- First Posted Date
- 2014-03-19
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Teva Pharmaceutical Industries, Ltd.
- Target Recruit Count
- 65
- Registration Number
- NCT02092077
- Locations
- 🇧🇾
Teva Investigational Site 68016, Minsk, Belarus
🇧🇬Teva Investigational Site 59060, Varna, Bulgaria
🇬🇪Teva Investigational Site 81022, Tbilisi, Georgia
TL011 in Severe, Active Rheumatoid Arthritis Patients
- Conditions
- Interventions
- First Posted Date
- 2010-05-14
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- Teva Pharmaceutical Industries, Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT01123070
- Locations
- 🇨🇿
Teva Investigational Site 5428, Plzen, Czechia
🇨🇿Teva Investigational Site 5426, Prague 2, Czechia
🇨🇿Teva Investigational Site 5429, Uherske Hradiste, Czechia
An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease
- Conditions
- Interventions
- First Posted Date
- 2008-09-03
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Teva Pharmaceutical Industries, Ltd.
- Target Recruit Count
- 257
- Registration Number
- NCT00745615
- Locations
- 🇩🇪
Teva Investigational Site 681, Berlin, Germany
🇷🇺Teva Investigational Site 185, St. Petersburg, Russian Federation
🇭🇺Teva Investigational Site 581, Gyula, Hungary
Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
- Conditions
- Interventions
- First Posted Date
- 2006-05-17
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Teva Pharmaceutical Industries, Ltd.
- Target Recruit Count
- 366
- Registration Number
- NCT00326625
- Locations
- 🇫🇷
Teva France, Paris, France
🇧🇪Teva Benelux, Leuven, Belgium
🇩🇪Teva Germany, Morfelden-Walldorf, Germany